Cecilia Martini

ORCID: 0000-0001-8262-1203
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoplatforms for cancer theranostics
  • Photodynamic Therapy Research Studies
  • Nanoparticle-Based Drug Delivery
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Dyeing and Modifying Textile Fibers
  • Cancer, Hypoxia, and Metabolism
  • Skin Protection and Aging
  • Layered Double Hydroxides Synthesis and Applications
  • HIV/AIDS drug development and treatment
  • Advanced Drug Delivery Systems
  • Ferroelectric and Piezoelectric Materials
  • Cancer therapeutics and mechanisms
  • Supramolecular Self-Assembly in Materials
  • Bone Tissue Engineering Materials
  • Tryptophan and brain disorders
  • RNA Interference and Gene Delivery

Institute of Organic Synthesis and Photoreactivity
2016-2024

National Research Council
2018-2024

University of Parma
2018

National Academies of Sciences, Engineering, and Medicine
2016

The potential anticancer effect of fluoroquinolone antibiotics has been recently unveiled and related to their ability interfere with DNA topoisomerase II. We herein envisioned the design synthesis novel Ciprofloxacin Norfloxacin nitric oxide (NO) photo-donor hybrids explore synergistic antitumor exerted by scaffold NO eventually produced upon light irradiation. Anticancer activity, evaluated on a panel tumor cell lines, showed encouraging results IC50 values in low micromolar range. Some...

10.1021/acs.jmedchem.1c00917 article EN cc-by Journal of Medicinal Chemistry 2021-07-28

Chlorin e6-conjugated keratin nanoparticles were obtained and their effectiveness as carriers for cancer photodynamic therapy was demonstrated<italic>in vitro</italic>.

10.1039/c6ra04208b article EN RSC Advances 2016-01-01

Triple-negative breast cancer (TNBC) is an aggressive subtype of still lacking effective treatment options. Chemotherapy in combination with immunotherapy can restrict tumor progression and repolarize the microenvironment towards anti-tumor milieu, improving clinical outcome TNBC patients. The chemotherapeutic drug paclitaxel has been shown to induce immunogenic cell death (ICD), whereas inhibitors indoleamine 2,3- dioxygenase 1 (IDO1) enzyme, whose expression shared immune regulatory cells,...

10.3389/fchem.2024.1378233 article EN cc-by Frontiers in Chemistry 2024-03-27

Exploiting the tumor environment features (EPR effect, elevated glutathione, reactive oxygen species levels) might allow attaining a selective and responsive carrier capable of improving therapeutic outcome. To this purpose, in situ covalent binding drugs nanoparticles to circulating human serum albumin (HSA) represent pioneering approach achieve an effective strategy. This study describes synthesis, vitro vivo evaluation bioresponsive HSA-binding (MAL-PTX2S@Pba), co-delivering two different...

10.3390/cancers14040877 article EN Cancers 2022-02-10

Hydrotalcites-like compounds, also known as anionic clays or layered double hydroxides, represent the only example of lamellar solid with positively charged layers and exchangeable interlayer anions. In this study, a nanostructured HTlc formula [Zn0.72Al0.28(OH)2] Br0.28·0.69 H2O was used inorganic drug delivery system for anticancer therapy. Two different molecules were selected being separately intercalated into ZnAl-HTlc: norcantharidin, inducing cell cycle arrest at G2/M phase,...

10.1021/acsanm.8b01601 article EN ACS Applied Nano Materials 2018-11-02

Triple-negative breast cancer (TNBC) is an aggressive subtype of still lacking effective treatment options. Chemotherapy in combination with immunotherapy can restrict tumor progression and repolarize the microenvironment towards anti-tumor milieu, improving clinical outcome TNBC patients. The chemotherapeutic drug paclitaxel had been shown to induce immunogenic cell death (ICD), whereas inhibitors indoleamine 2,3-dioxygenase 1 (IDO1), whose expression shared immune regulatory cells, have...

10.26434/chemrxiv-2023-h5h2z preprint EN cc-by-nc-nd 2023-08-24
Coming Soon ...